Related references
Note: Only part of the references are listed.Differential Requirements of Hsp90 and DNA for the Formation of Estrogen Receptor Homodimers and Heterodimers
Emily Powell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phase 2 Trial of Mifepristone (RU-486) in Advanced or Recurrent Endometrioid Adenocarcinoma or Low-Grade Endometrial Stromal Sarcoma
Lois M. Ramondetta et al.
CANCER (2009)
Non-competitive androgen receptor inhibition in vitro and in vivo
Jeremy O. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Amphipathic benzenes are designed inhibitors of the estrogen receptor α/steroid receptor coactivator interaction
Jillian R. Gunther et al.
ACS CHEMICAL BIOLOGY (2008)
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor
Andrew L. LaFrate et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Tamoxifen stimulates the growth of cyclin D1 - Overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3
Yuki Ishii et al.
CANCER RESEARCH (2008)
Low Concentrations of the Soy Phytoestrogen Genistein Induce Proteinase Inhibitor 9 and Block Killing of Breast Cancer Cells by Immune Cells
Xinguo Jiang et al.
ENDOCRINOLOGY (2008)
A new small molecule inhibitor of estrogen receptor α binding to estrogen response elements blocks estrogen-dependent growth of cancer cells
Chengjian Mao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Regulation of Estrogen Receptor-mediated Long Range Transcription via Evolutionarily Conserved Distal Response Elements
You Fu Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tamoxifen-stimulated growth of breast cancer due to p21 loss
Abde M. Abukhdeir et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Progressive loss of estrogen receptor α cofactor recruitment in endocrine resistance
Catherine Naughton et al.
MOLECULAR ENDOCRINOLOGY (2007)
A surface on the androgen receptor that allosterically regulates coactivator binding
Eva Estebanez-Perpina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A functional serine 118 phosphorylation site in estrogen receptor-α is required for down-regulation of gene expression by 17β-estradiol and 4-hydroxytamoxifen
Jingwei Cheng et al.
ENDOCRINOLOGY (2007)
Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosis
J. A. Kummer et al.
CELL DEATH AND DIFFERENTIATION (2007)
Predictors of response to aromatase inhibitors
Helen Anderson et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Fulvestrant (Faslodex®) -: How to make a good drug better
John F. R. Robertson
ONCOLOGIST (2007)
Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells
X. Jiang et al.
ONCOGENE (2007)
In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors α and β supports an active displacement model for coregulator utilization
Stanley Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity
Thomas D. Cunningham et al.
CELLULAR IMMUNOLOGY (2007)
Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer
Li Hua Wang et al.
CANCER CELL (2006)
Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells
Robin L. Kilker et al.
CANCER RESEARCH (2006)
Long-term administration of mifepristone (RU486): Clinical tolerance during extended treatment of meningioma
Steven M. Grunberg et al.
CANCER INVESTIGATION (2006)
Estrogen receptor target gene: An evolving concept
Jason S. Carroll et al.
MOLECULAR ENDOCRINOLOGY (2006)
Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells
XG Jiang et al.
ENDOCRINOLOGY (2006)
Estrogen receptors and human disease
BJ Deroo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Altered target gene regulation controlled by estrogen receptor-α concentration
AM Fowler et al.
MOLECULAR ENDOCRINOLOGY (2006)
MUC1 oncoprotein stabilizes and activates estrogen receptor α
XL Wei et al.
MOLECULAR CELL (2006)
Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression
M Grillo et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance
JS Lewis et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma
IS van Houdt et al.
CLINICAL CANCER RESEARCH (2005)
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
JS Carroll et al.
CELL (2005)
Selective estrogen-receptor modulators for primary prevention of breast cancer
CJ Fabian et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes
AJ Krieg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Characterization of new estrogen receptor destabilizing compounds:: Effects on estrogen-sensitive and tamoxifen-resistant breast cancer
J Hoffmann et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists
VS Wilson et al.
TOXICOLOGICAL SCIENCES (2004)
Genomic targets of nuclear estrogen receptors
R O'Lone et al.
MOLECULAR ENDOCRINOLOGY (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance
R Schiff et al.
CLINICAL CANCER RESEARCH (2004)
Increases in estrogen receptor-alpha concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen
AM Fowler et al.
FASEB JOURNAL (2004)
ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects - a review
RL ten Berge et al.
JOURNAL OF PATHOLOGY (2003)
ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified
RL ten Berge et al.
HISTOPATHOLOGY (2003)
Minireview: Nuclear receptor coactivators - An update
NJ McKenna et al.
ENDOCRINOLOGY (2002)
Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma
RL ten Berge et al.
BLOOD (2002)
Molecular determinants for the tissue specificity of SERMs
YF Shang et al.
SCIENCE (2002)
Combinatorial control of gene expression by nuclear receptors and coregulators
NJ McKenna et al.
CELL (2002)
A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1β-converting enzyme (caspase 1)
SA Krieg et al.
MOLECULAR ENDOCRINOLOGY (2001)
Duration of nuclear NF-κB action regulated by reversible acetylation
LF Chen et al.
SCIENCE (2001)
Estrogen-regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements
E Castro-Rivera et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway
M Jakacka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Estrogen receptor pathways to AP-1
PJ Kushner et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2000)
Share Paper
